Gastrointestinal (GI) Stent Market Size to Reach USD 958.81 Million by 2034 at a 5.62% CAGR from 2026 to 2034

The gastrointestinal stent market size was valued at USD 586.23 million in 2025 and is expected to reach USD 958.81 million by 2034, growing at a CAGR of 5.62%. GI stents involve minimally invasive devices that support and reopen obstructed digestive tract sections through medical intervention, improving passage of contents and managing conditions such as strictures, cancers, and blockages.

Key Statistics:

• Market Size (2025): USD 586.23 million
• Market Size (2034): USD 958.81 million
• CAGR (2026-2034): 5.62%
• Dominating Region: North America

Report Highlights:

• Rising number of gastrointestinal cancer is increasing demand for GI stents.
• Shift towards minimally invasive procedure is driving the growth of GI stents.
• High device costs are creating market challenges.
• Development of biodegradable stents are creating long-term opportunities.
• Biliary stent dominated the market in 2025, driven by the rising prevalence of biliary obstructions caused by conditions such as pancreatic cancer and gallstones.
• North America led the market driven by high prevalence of colorectal cancer and strong awareness regarding minimally invasive treatment options.
• Key companies include Merit Medical Systems, Inc., ELLA-CS, s.r.o., Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, and others.

What’s Included in Gastrointestinal Stent Report?

The report presents a detailed overview of the market for gastrointestinal stent based on product type, material type, application, and end-use industry. It includes regional analysis, treatment ecosystem, value chain assessment, and competitive landscape.

What are Driving Factors and Emerging Trends of Gastrointestinal Stent Market?

As per our analysis, the market is increasing due to rising number of gastrointestinal cancer and shift towards minimally invasive procedure. The major factors that are responsible for the growth of the gastrointestinal stent market are:

• Rising GI Cancer: Rising number of gastrointestinal cancer is driving the demand for GI stents. American Cancer Society stated that the number of GI cancer is projected to reach 9.06 million globally by 2050.

• Shift Towards Minimally Invasive Procedure: The growing preference for minimally invasive techniques results in the increased use of endoscopy treatment. National Library of Medicine reported that the adoption of minimally invasive surgical procedure rose from 51.2% in 2012 to 93.6% in 2024.

• Development of Biodegradable Stents: Biodegradable stents eliminate the need for removal procedures after treatment.

These factors are aligned with the increasing demand for advanced endoscopic treatments and the growing adoption of patient-friendly, minimally invasive solutions in gastrointestinal care.

Request a free sample copy or read the full market insights: Gastrointestinal Stent Market Report

Which Key Segments are Driving Gastrointestinal Stent Market?

By Product Type Analysis

Biliary stent segment held the largest market share due to the rising prevalence of biliary obstructions caused by conditions such as pancreatic cancer and gallstones.

By Material Type Analysis

Metal stent segment dominated the market driven by their superior durability, and higher clinical effectiveness compared to other stent types.

By Application Analysis

Biliary disease segment dominated the market due to high incidence of diseases including bile duct obstruction and strictures.

By End-Use Industry Analysis

Hospitals segment dominated the market in 2025, driven by high procedure volume and access to advanced endoscopic infrastructure.

Which is Dominating Region in Gastrointestinal Stent Market?

North America: North America dominated in 2025 driven by high prevalence of colorectal cancer and strong awareness regarding minimally invasive treatment options. The US Cancer Statistics reported that the US recorded 147,931 new colorectal cancer cases in 2022, and 53,779 people died from colorectal cancer in 2023.

Asia Pacific: Asia Pacific is expected to grow at the fastest rate due to rising prevalence of gastrointestinal diseases.

Where is Gastrointestinal Stent Market Headed?

According to analysis, the market is moving toward steady expansion supported by advanced stent technologies, and expanding minimally invasive treatment solutions.

What Gastrointestinal Stent Market Report Reveals?

• What is the global market size, growth trend, and CAGR for gastrointestinal stent through 2034?
• What are the factors driving the market growth?
• Who are the top companies, and what is their relative position in terms of competitive positioning?
• How are providers advancing technologies to improve stent quality?
• How is the application of biodegradable stents shaping the gastrointestinal stent market?
• What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
• Where do new opportunities arise in the gastrointestinal stent market?

Who are Major Gastrointestinal Stent Market Contributors?

According to our study, a few firms are leading in the global market. The following are some of the major market contributors:

• Merit Medical Systems, Inc.
• ELLA-CS, s.r.o.
• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical LLC
• Medtronic plc
• HOBBS MEDICAL, INC.
• Becton, Dickinson and Company
• Taewoong Medical Co., Ltd.
• Micro-Tech (Nanjing) Co., Ltd.
• ENDO-FLEX GmbH
• M.I.Tech Co., Ltd.

Market Segments Covered

By Product Type Outlook (Revenue, USD Million, 2021-2034)

• Biliary Stent
• Esophageal Stent
• Colonic Stent
• Pancreatic Stent
• Duodenal Stent

By Material Type Outlook (Revenue, USD Million, 2021-2034)

• Metal Stent
• Biodegradable Stent
• Plastic Stent

By Application Outlook (Revenue, USD Million, 2021-2034)

• Gastrointestinal Cancer
• Biliary Disease
• Colorectal Cancer
• Stomach Cancer
• Others

By End-Use Industry Outlook (Revenue, USD Million, 2021-2034)

• Hospitals
• Ambulatory Surgical Centers
• Others

By Regional Outlook (Revenue, USD Million, 2021-2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of Middle East & Africa